000			02065 a2200529 4500
005			20250516031949.0
264		0	_c20130405
008			201304s 0 0 eng d
022			_a1873-2496
024	7		_a10.1016/j.urolonc.2010.11.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aHara, Noboru
245	0	0	_aInsulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer. _h[electronic resource]
260			_bUrologic oncology _cSep 2012
300			_a596-601 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenocorticotropic Hormone _xblood
650	0	4	_aAged
650	0	4	_aAndrogen Antagonists _xadministration & dosage
650	0	4	_aAntineoplastic Agents, Hormonal _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aDehydroepiandrosterone Sulfate _xblood
650	0	4	_aFlutamide _xadministration & dosage
650	0	4	_aGoserelin _xadministration & dosage
650	0	4	_aHuman Growth Hormone _xblood
650	0	4	_aHumans
650	0	4	_aImmunoassay _xmethods
650	0	4	_aInsulin-Like Growth Factor I _xmetabolism
650	0	4	_aLogistic Models
650	0	4	_aLuteinizing Hormone _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aOutcome Assessment, Health Care
650	0	4	_aProspective Studies
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatic Neoplasms _xblood
650	0	4	_aTestosterone _xblood
700	1		_aTakizawa, Itsuhiro
700	1		_aIsahaya, Etsuko
700	1		_aNishiyama, Tsutomu
700	1		_aHoshii, Tatsuhiko
700	1		_aIshizaki, Fumio
700	1		_aTakahashi, Kota
773	0		_tUrologic oncology _gvol. 30 _gno. 5 _gp. 596-601
856	4	0	_uhttps://doi.org/10.1016/j.urolonc.2010.11.001 _zAvailable from publisher's website
999			_c20726634 _d20726634